ProQuad普眾欣

ProQuad Description

Manufacturer:

MSD

Distributor:

Zuellig
/
Agencia Lei Va Hong
Full Prescribing Info
Description
After reconstitution, one dose (0.5 ml) contains: Measles virus1 Enders' Edmonston strain (live, attenuated) not less than 3.00 log10 TCID50*.
Mumps virus1 Jeryl Lynn (Level B) strain (live, attenuated) not less than 4.30 log10 TCID50*.
Rubella virus2 Wistar RA 27/3 strain (live, attenuated) not less than 3.00 log10 TCID50*.
Varicella virus3 Oka/Merck strain (live, attenuated) not less than 3.99 log10 PFU**.
*50% tissue culture infectious dose.
**plaque‐forming units.
(1) Produced in chick embryo cells.
(2) Produced in human diploid lung (WI‐38) fibroblasts.
(3) Produced in human diploid (MRC‐5) cells.
The vaccine may contain traces of recombinant human albumin (rHA).
This vaccine contains a trace amount of neomycin. See Contraindications.
Before reconstitution, the powder is a white to pale yellow compact crystalline cake and the solvent is a clear colourless liquid.
Excipients with known effect: The vaccine contains 16 mg of sorbitol. See Precautions.
Excipients/Inactive Ingredients: Powder: Sucrose, Gelatin, Sodium chloride, Sorbitol, Monosodium L‐Glutamate Monohydrate, Sodium phosphate, Sodium bicarbonate, Potassium phosphate, Potassium chloride, Medium 199 with Hanks' Salts, Eagle Minimum Essential Medium, Neomycin, Phenol red, Urea.
Solvent: Water for injections.
Exclusive offer for doctors
Register for a MIMS account and receive free medical publications worth $768 a year.
Sign up for free
Already a member? Sign in